The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch

Podbit · The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch

20VC: $5BN in Revenue, 7 to 7,000 Employees in 9 Months, 206,000 Tests in a Single Day: The Craziest Story in Startups: Curative with Fred Turner

Explore episode Jul 18, 2026
Health & Fitness
Why US Healthcare Is Broken: Market Consolidation

20VC: $5BN in Revenue, 7 to 7,000 Employees in 9 Months, 20… · Jul 18, 2026 Health & Fitness

The US healthcare market has consolidated into roughly four giant payers and massive hospital systems — each built big just to survive negotiations with the other. The result is a market where neither side has a viable alternative, so everyone overpays and nothing changes. Fred Turner argues breaking it into smaller units is the only fix.

Similar podbits

Health & Fitness
The 30-Day Calorie Competition With Neighbors

Ep 621 - Landlubbers · Jul 20, 2026 Health & Fitness

Shane and two neighbors are competing to burn the most calories in June. He's on pace for 35,000 and has had zero rest days in 30 days. He monitors neighbors' workout alerts like enemy dispatches and worries daily about dying in the pool.

Health & Fitness
Dancing Is the Ultimate Neuroplasticity Exercise

Accelerate Learning & Increase Cognitive Capacity | Dr. Tom… · Jul 20, 2026 Health & Fitness

Meta-analyses of interventions in older adults show that ballroom and line dancing produce the greatest improvements in cognitive function. Unlike digital brain training, dancing combines motor skill acquisition, social interaction, musical timing, and physical exercise — hitting multiple neural networks simultaneously.

Health & Fitness
The Shingles Vaccine May Be Protecting Against Dementia

Accelerate Learning & Increase Cognitive Capacity | Dr. Tom… · Jul 20, 2026 Health & Fitness

Natural experiments in Wales, Australia, and Canada — where eligibility switched based on birth date — consistently showed lower dementia rates among shingles vaccine recipients. The newer Shingrix vaccine appears more protective than the older Zostavax. The leading hypothesis is an immunomodulatory effect that may also suppress other neurotropic herpesviruses.